A recent study in precursor B-cell acute lymphoblastic leukemia revealed that pre-BCR signaling regulates PI3K/AKT, FOXO1 and MYC and can be a target of SYK inhibition [45]. The gene discussed is BCR; the disease is B-cell acute lymphoblastic leukemia.